These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37349201)

  • 41. Actionable imaging findings in the daily PET/CT scenario.
    Mattana F; Zanoni L; Nanni C; Mosconi C; Brocchi S; Golfieri R; Fanti S
    Clin Transl Imaging; 2023; 11(2):127-139. PubMed ID: 36846503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
    Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.
    Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R
    Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDG-PET/CT for oral focus assessment in head and neck cancer patients.
    Schwaninger DR; Hüllner M; Bichsel D; Giacomelli-Hiestand B; Stutzmann NS; Balermpas P; Valdec S; Stadlinger B
    Clin Oral Investig; 2022 Jun; 26(6):4407-4418. PubMed ID: 35254526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.
    Flygare L; Erdogan ST; Söderkvist K
    Acta Radiol; 2023 May; 64(5):1865-1872. PubMed ID: 36464816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [What does the nonradiologist expect from the radiologist?].
    Kasper S; Virchow I; Hadaschik B; Radtke JP
    Radiologe; 2020 May; 60(5):421-429. PubMed ID: 32052117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PET-MRI for evaluation of response to radiochemotherapy in patients with locally advanced cervical cancer.
    Weyl A; Chollet C; Gabiache E; Cancès-Lauwers V; Gallo F; Martinez A; Courbon F; Leguevaque P; Brenot Rossi I; Jalaguier A; Lambaudie E; Chantalat E; Motton S
    Int J Gynecol Cancer; 2023 May; 33(5):676-682. PubMed ID: 36822657
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Grobman M; Cohn L; Knapp S; Bryan JN; Reinero C
    Vet Radiol Ultrasound; 2018 Jan; 59(1):107-115. PubMed ID: 28925085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imaging in myeloma: a Royal College of Radiologists national survey of current imaging practice.
    Westerland O; Drinkwater KJ; Parikh J; Streetly M; Pratt G; Goh V; Howlett DC
    Clin Radiol; 2021 Nov; 76(11):820-828. PubMed ID: 34187681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recommendations in Clinical
    Alesawi HM; Kwee TC; Glaudemans AWJM; Yakar D
    J Am Coll Radiol; 2018 Sep; 15(9):1269-1275. PubMed ID: 30064891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comorbidity Assessment in Patients With Oral Squamous Cell Carcinoma: Can Imaging Techniques (Fludeoxyglucose Positron-Emission Tomographic Computed Tomography and Contrast-Enhanced Computed tomography) Provide Additional Information?
    Troeltzsch M; Probst FA; Rominger A; Müller-Lisse U; Probst M; Obermeier K; Ehrenfeld M; Otto S
    J Oral Maxillofac Surg; 2018 Jan; 76(1):190-198. PubMed ID: 28646645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of
    McDonald EO; Amanullah AA; Park PSU; Song W; Werner TJ; Alavi A; Revheim ME
    Ann Nucl Med; 2023 Jun; 37(6):328-348. PubMed ID: 37095393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An International Survey of PET/CT Clinical Reporting.
    Zukotynski KA; Niederkohr RD; Greenspan BS; Prior JO; Schöder H; Seltzer MA; Rohren EM; Yoo DC
    J Nucl Med; 2019 Apr; 60(4):478-479. PubMed ID: 30877176
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
    Zhang C; Liang Z; Liu W; Zeng X; Mo Y
    BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
    Omarov N; Uymaz DS; Kulle CB; Ozkan ZG; Azamat S; Keskin M; Bulut MT
    Pol Przegl Chir; 2022 Feb; 94(6):10-16. PubMed ID: 36468505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A data-driven respiratory motion estimation approach for PET based on time-of-flight weighted positron emission particle tracking.
    Tumpa TR; Acuff SN; Gregor J; Lee S; Hu D; Osborne DR
    Med Phys; 2021 Mar; 48(3):1131-1143. PubMed ID: 33226647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients.
    Seith F; Gatidis S; Schmidt H; Bezrukov I; la Fougère C; Nikolaou K; Pfannenberg C; Schwenzer N
    Invest Radiol; 2016 Jan; 51(1):66-71. PubMed ID: 26348596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.